{{if listFind(vars.channel_names, "MSIF News")}}

{{endif}}

{{if listFind(vars.channel_names, "MSIF News")}}

{{endif}}

{{if listFind(vars.channel_names, "People With MS News")}}

{{endif}}

{{if listFind(vars.channel_names, "People With MS News")}}

{{endif}}

{{if listFind(vars.channel_names, "Research News")}}

{{endif}}

{{if listFind(vars.channel_names, "Research News")}}

{{endif}}

{{if listFind(vars.channel_names, "MS Society News")}}

{{endif}}

{{if listFind(vars.channel_names, "MS Society News")}}

{{endif}}

MSIF 2007 Du Pré Grants update

MSIF has awarded a further two Du Pré Grants to young MS researchers in the second round of the 2007 awards. The researchers, Dr Jennifer Somerfield from New Zealand and Dr Ingrid van der Mei from the Netherlands, will undertake MS research projects in the UK and USA respectively.

read more

MSIF’s 2007 McDonald Fellowship news

This year MSIF awarded five McDonald Fellowships to young MS researchers from Argentina, Brazil, Romania, Spain and Thailand.

read more

back to top

Profile of the Month : January 2008

Name:
Ninfa Monarres Madrid
Country: Mexico
Age: 48
Profession: Childcare worker
Type of MS: RRMS
Year of diagnosis: 1999

'...I loved my job and was promoted to director, when I received an unexpected visit from MS, a friend I share with people all over the world: in Mexico alone there are 15,000 people with MS...'

Italiano Deutsche English Espanol Francais

back to top

The role of optical coherence tomography in multiple sclerosis: Expert panel consensus.

This expert panel review looks at OCT, a new non-invasive way of looking at nerve fibre loss in MS, which may be very useful in future trials.

authors: Sergott RC, Frohman E, Glanzman R, Al-Sabbagh A; on behalf of the OCT in MS Expert Panel.

source: J Neurol Sci. 2007 Dec 15;263(1-2):3-14. Epub 2007 Jul 27.

read more

One-year follow-up to a randomized controlled trial of an energy conservation course for persons with multiple sclerosis.

This trial found a community-based course was an effective method of managing fatigue in MS.

authors: Mathiowetz VG, Matuska KM, Finlayson ML, Luo P, Chen HY.

source: Int J Rehabil Res. 2007 Dec;30(4):305-313.

read more

Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain

The role of infective agents in MS is still unproven. The authors describe some evidence for one possible candidate, Epstein Barr virus.

authors: Serafini B, Rosicarelli B, Franciotta D, Magliozzi R, Reynolds R, Cinque P, Andreoni L, Trivedi P, Salvetti M, Faggioni A, Aloisi F.

source: J Exp Med. 2007 Nov 5; [Epub ahead of print]

read more

Bacterial toxins and Multiple Sclerosis

This article reviews evidence for a possible role of bacteria in the pathogenesis of MS.

authors: Gay F.

source: J Neurol Sci. 2007 Nov 15;262(1-2):105-12. Epub 2007 Aug 20.

read more

HTLV-1 infection and the viral etiology of multiple sclerosis

Author hypothesises whether another virus, HTLV-1, could be implicated in MS.

authors: Oger J.

source: J Neurol Sci. 2007 Nov 15;262(1-2):100-4. Epub 2007 Aug 6.

read more

Prognostic value of high-field proton magnetic resonance spectroscopy in patients presenting with clinically isolated syndromes suggestive of multiple sclerosis

This study found that markers of nerve fibre damage, measured with a recently developed MRI technique, helped predict which people would go on to develop MS after a single attack of neurological dysfunction.

authors: Wattjes MP, Harzheim M, Lutterbey GG, Bogdanow M, Schmidt S, Schild HH, Träber F.

source: Neuroradiology. 2007 Nov 3; [Epub ahead of print]

read more

back to top

UK: Amiloride trials show promise for MS

British researchers say Amiloride, a drug which has been used for decades to treat high blood pressure, may turn out to be a key treatment for MS.

read more

US: B Cells in Autoimmunity and Multiple Sclerosis symposium

The B Cells in Autoimmunity and Multiple Sclerosis symposium, held from 29-30 November 2007 in Santa Monica and organised by BioSymposia, emphasises the roles that B cells play as effectors and regulators in autoimmunity, the pathogenesis of MS, and the importance of antibodies to CNS antigens in the disease process.

read more

UK: ‘What Can Science Do for Me?’ MS documentary now available online

The UK MS Society has joined forces with the Community Channel to create an inspiring documentary, exploring the role of science in MS.

read more

back to top

Tell a friend

The email you subscribed with us is {{print email}}

Within this newsletter the following options are available: MSIF News; People with MS News; Research News and MS Society News. To amend your options please login to the 'My world of MS' online community where you can also read diary entries from people affected by MS, leave your own diary entries and send messages to other users. You can also change your email address, contact details and subscribe to our free publications.

If you have an RSS News Reader you can get the latest news syndicated to you by copying the following link to your Reader: Syndicate.

If you do not want to receive future issues of this newsletter or if you have received this in error, please accept our apologies and simply unsubscribe here

Multiple Sclerosis International Federation
3rd Floor Skyline House, 200 Union Street, SE1 0LX
Tel: +44 (0) 20 7620 1911
Fax: +44 (0) 20 7620 1922
Registered Charity: 1105321
Email: info@msif.org

 Click here to learn more about the work of the Making Connections sponsor.